Methotrexate-induced changes in rat parotid and submandibular gland function

Journal of Dental Research
|September 1, 1987
PubMed

Insights

Methotrexate (MTX) treatment in rats reduced salivary gland weight and function. This study investigated MTX

Area of Science:

  • Biochemistry
  • Physiology
  • Pharmacology

Background:

  • Methotrexate (MTX) is a chemotherapy agent and immunosuppressant.
  • Salivary glands are crucial for oral health and digestion.
  • Understanding MTX's effects on salivary glands is important for managing side effects.

Purpose of the Study:

  • To investigate the effects of MTX on rat salivary gland function.
  • To examine changes in gland weight, RNA, and amylase content.
  • To assess the impact of MTX on ion transport in salivary ducts.

Main Methods:

  • Adult rats received daily intraperitoneal injections of MTX (15 mg/kg) for three consecutive days.
  • Salivary gland weight, RNA, and amylase content were measured.
  • Sodium, chloride, and potassium outputs were analyzed in parotid and submandibular glands.
  • Ductal perfusion was used to study ion transport in submandibular glands.

Main Results:

  • MTX significantly decreased unstimulated parotid gland weight, RNA, and amylase content compared to controls.
  • Submandibular gland RNA content was also reduced by MTX.
  • Parotid and submandibular gland outputs of sodium and chloride decreased, while potassium output remained unchanged.
  • Ductal perfusion revealed a reduced net efflux of sodium and chloride from the submandibular gland excretory duct.

Conclusions:

  • MTX administration impairs salivary gland function, affecting weight, protein synthesis, and ion transport.
  • The observed effects on gland weight, RNA, and amylase suggest inhibition of protein synthesis.
  • The precise mechanism underlying MTX-induced alterations in salivary gland ion transport requires further investigation.

Related Concept Videos